When Guidelines Cause Hypertension - 23/01/19
Doi : 10.1016/j.amjmed.2018.06.007
Nicholas Wald, FRS, FRCP a, ⁎ 
, David Wald, FRCP a, Arthur L. Kellermann, MD b
, David Wald, FRCP a, Arthur L. Kellermann, MD b a Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK
b F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Md
⁎Requests for reprints should be addressed to Nicholas Wald, FRS, FRCP, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of LondonCharterhouse SquareLondonEC1M 6BQUK
Le texte complet de cet article est disponible en PDF.
| Funding: None. |
|
| Conflict of Interest: NW is a director of Polypill Ltd, which provides a UK online medical service (polypill.com) offering preventive medication to eligible individuals and is the co-inventor of polypill formulations for the prevention of cardiovascular disease. DW is a co-founder of Polypill Ltd. ALK has no conflict of interest to declare. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 131 - N° 12
P. 1402-1404 - décembre 2018 Retour au numéro
Article précédent
- Advanced Therapies for Massive Pulmonary Embolism
- James E. Dalen
- Medical Principles in Obstetrical Consults
- Jonathan S. Zipursky, Donald A. Redelmeier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?